Related references
Note: Only part of the references are listed.An intestinal stem cell niche in Apc mutated neoplasia targetable by CtBP inhibition
Ayesha T. Chawla et al.
Oncotarget (2018)
Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasia
E. T. Sumner et al.
ONCOGENE (2017)
Ctbp2-mediated β-catenin regulation is required for exit from pluripotency
Tae Wan Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors
M. Michael Dcona et al.
CANCER BIOLOGY & THERAPY (2017)
MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies
E. Hessmann et al.
ONCOGENE (2016)
Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP)
Sudha Korwar et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Genetics and biology of pancreatic ductal adenocarcinoma
Haoqiang Ying et al.
GENES & DEVELOPMENT (2016)
Ctbp2 Modulates NuRD-Mediated Deacetylation of H3K27 and Facilitates PRC2-Mediated H3K27me3 in Active Embryonic Stem Cell Genes During Exit from Pluripotency
Tae Wan Kim et al.
STEM CELLS (2015)
CtBP2 could promote prostate cancer cell proliferation through c-Myc signaling
Changwen Zhang et al.
GENE (2014)
Cancer stem cells: The challenges ahead
Jan Paul Medema
NATURE CELL BIOLOGY (2013)
BRCA1 Expression Is Epigenetically Repressed in Sporadic Ovarian Cancer Cells by Overexpression of C-Terminal Binding Protein 2
Taymaa May et al.
NEOPLASIA (2013)
Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance
Charles N. Birts et al.
BIOLOGY OF THE CELL (2011)
An ARF/CtBP2 complex regulates BH3-only gene expression and p53-independent apoptosis
R. C. Kovi et al.
CELL DEATH AND DIFFERENTIATION (2010)
CHEMOTHERAPY Gemcitabine remains the standard of care for pancreatic cancer
Jordan Berlin et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
Bin-Bing S. Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Development of an optimal antigen retrieval protocol for immunohistochemistry of retinoblastoma protein (pRB) in formalin fixed, paraffin sections based on comparison of different methods
S-R Shi et al.
BIOTECHNIC & HISTOCHEMISTRY (2007)
ESR1, AR, body size, and breast cancer risk in Hispanic and non-Hispanic white women living in the Southwestern United States
Martha L. Slattery et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Overlapping and unique roles for C-terminal binding protein 1 (CtBP1) and CtBP2 during mouse development.
JD Hildebrand et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Share Paper
